Liposomal doxorubicin improves response to immune checkpoint blockade by enhancing innate immunity in a murine model of oral cavity squamous cell carcinoma

被引：0
|
作者：
Anderson, Jennifer L.
Da Costa, Fabio H. Brasil
Nipper, Allison
Devkota, Laxman
Bhavane, Rohan
Veeramachaneni, Ratna
Cortes, Sofia
Dharmaraj, Neeraja
Latka, Sarah
Badachhape, Andrew
Menon, Renuka T. R.
Bhandari, Prajwal
Ghaghada, Ketankumar
Young, Simon
Annapragada, Ananth
Sikora, Andrew
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-A119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A119
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Characterization of the orthotopic MMTV PyMT murine mammary carcinoma model following radiation and immune checkpoint blockade
    Trachet, Erin E.
    Germain, Derrik Germain
    Urs, Sumithra
    Draper, David
    Franklin, Maryland Rosenfeld
    CANCER RESEARCH, 2020, 80 (16)
  • [42] AZD2171 in combination with paclitaxel is an effective therapy for oral cavity squamous cell carcinoma in a murine orthotopic model
    Gomez-Rivera, F.
    Santillan-Gomez, A.
    Fooshee, D.
    Gallagher, K.
    Zhao, M.
    Sung, A.
    Gu, M.
    Jasser, S.
    Myers, J. N.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 110 - 111
  • [43] Stress keratin 17 as a novel biomarker of response in immune checkpoint blockade-treated head and neck squamous cell carcinoma.
    Lozar, Taja
    Fitzpatrick, Megan
    Wang, Wei
    Bailey, Howard Harry
    Bruce, Justine Yang Yang
    Harari, Paul M.
    Lambert, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma
    Panda, Anshuman
    de Cubas, Aguirre A.
    Stein, Mark
    Riedlinger, Gregory
    Kra, Joshua
    Mayer, Tina
    Smith, Christof C.
    Vincent, Benjamin G.
    Serody, Jonathan S.
    Beckermann, Kathryn E.
    Ganesan, Shridar
    Bhanot, Gyan
    Rathmell, W. Kimryn
    JCI INSIGHT, 2018, 3 (16):
  • [45] Predicting response to immune checkpoint blockade in recurrent/metastatic head and neck squamous cell carcinoma using personalized circulating tumor DNA
    Torres, Daniel A. Ruiz
    Merkin, Ross D.
    Mendel, Julia
    Fisch, Adam S.
    Roberts, Thomas J.
    Patel, Manisha Jayandra
    Park, Jong Chul
    Chevalier, Amber
    Murray, Clodagh
    Gates, Lisa
    Efthymiou, Vasileios
    Pipinikas, Christodoulos
    Wirth, Lori J.
    Faden, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Zheng, Dan-Dan
    Li, Yu-Ying
    Yuan, Xiao-Yi
    Lu, Jiang-Li
    Zhang, Mei-Fang
    Fu, Jia
    Zhang, Chris Zhiyi
    BMC CANCER, 2024, 24 (01)
  • [47] Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer.
    Cannon, T. L.
    Muggia, F.
    Hirsch, D.
    Andreopoulou, E. A.
    Kerr, A. R.
    DeLacure, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective
    Zou, Gengyi
    Anwar, Junaid
    Pizzi, Melissa P.
    Abdelhakeem, Ahmed
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 826 - 828
  • [49] Semaphorin 4D Blockade Enhances T-Cell Penetration and Potentiates Response to Immune Checkpoint Blockade in a Murine Model of Pancreatic Cancer
    Ruffolo, Luis I.
    Ullman, Nicholas A.
    Jackson, Katherine M.
    Burchard, Paul R.
    Fields, Ryan C.
    Yeh, Jen Jen
    Hernandez-Alejandro, Roberto
    Belt, Brian A.
    Zauderer, Maurice
    Linehan, David C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 233 (05) : S252 - S253
  • [50] CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma
    Zou, Ke-Long
    Lan, Zhou
    Cui, Hao
    Zhao, Yu-Yue
    Wang, Wei-Ming
    Yu, Guang-Tao
    ORAL DISEASES, 2024, 30 (02) : 163 - 171
12345